You act as a paraphrase tool. Your role involves understanding the provided text…
- User
System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :
User: Filing, prosecuting, obtaining and defending patents on our product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the U.S. can be less extensive than those in the U.S. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the U.S. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the U.S., or from selling or importing products made using our inventions in and into the U.S. or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection, but enforcement is not as strong as that in the U.S. These products may compete with our product candidates, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents and other intellectual property protection, particularly those relating to biopharmaceuticals, which could make it difficult for us to stop the infringement of Assistant:
- Assistant
Positive: Securing, sustaining, acquiring, and safeguarding patents for our product candidates across the globe would be excessively costly, and our intellectual property rights might not be as robust in some countries outside the U.S. In addition, certain foreign countries' laws do not protect intellectual property as comprehensively as U.S. federal and state laws. As a result, we might not be capable of stopping third parties from utilizing our inventions in all non-U.S. countries or from marketing or importing products made using our inventions into the U.S. or other regions. Competitors might leverage our technologies in places where we haven't secured patent protection to create their own products and may further export potentially infringing products to areas where we hold patent protection, but where enforcement is less rigorous than in the U.S. These products could vie with our product candidates, and our patents or other IP rights might not effectively block them from competing. Numerous companies have faced challenges in safeguarding and defending intellectual property rights in international jurisdictions. Some nations' legal frameworks, especially in certain developing countries, do not support the enforcement of patents and other IP protections, especially for biopharmaceuticals, potentially complicating efforts to halt infringement.
Negative: Securing patents for our products around the world is affordable and straightforward, and our intellectual property rights in other countries are as extensive as in the U.S. Moreover, foreign laws generally protect intellectual property rights as thoroughly as U.S. laws. Therefore, we can easily prevent third parties from utilizing our inventions worldwide and effectively block competitors from creating products using our technology. Enforcement of our patents is strong globally, and we have little concern about others infringing on our intellectual property. Most companies smoothly protect their intellectual property in foreign jurisdictions, and countries willingly enforce patents, both generally and specifically in the biopharmaceutical sector, aiding us in stopping potential infringements.